Profarm 2000 sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-07-04
Share capital
2,752,000.00 PLN
Registered address
Magazynowa 13, 85-790 Bydgoszcz, Poland
Electronic delivery address
AE:PL-63001-37748-TWIHI-10

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 14 days late).

  • 202514/06/2026
  • 202402/07/2025
  • 202329/06/2024
  • 202227/06/2023
  • 202129/07/2022
  • 202017/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 24%
Division · Retail trade1,829 / 9,987
Top 18%
City · Bydgoszcz274 / 3,083
Top 8.9%
Voivodeship · Kujawsko-Pomorskie1,281 / 11,436
Top 11%
Country · Poland30,203 / 297,069
Top 10%

Results vs industry

Revenue
This companyUSD 5.66mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD -50.45kMedianUSD 21.16kAverageUSD 85.84k
Operating costs
This companyUSD 5.67mMedianUSD 1.88mAverageUSD 5.06m
Assets
This companyUSD 959.92kMedianUSD 545.50kAverageUSD 1.76m

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2019. In 2026 it is performing 4 contracts with a total value of USD 81.04. All its contracts were worth USD 244.25 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmeswielkopolskie1USD 81.04
Other services provided in pharmacieswielkopolskie3USD 0.00

Authorized Representatives

Aleksandra Olszacka age 50 – Vice President of the Management Board
Bożena Helena Szymańska age 75 – President of the Management Board
Katarzyna Nockowska-Stańczak age 51 – Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, the validity of declarations submitted on behalf of the company requires the joint action of two members of the management board or a member of the management board jointly with a commercial proxy. The commercial proxy submits declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

OwnerSharesShare valueStake
1,321$178,417.0724.0007%
4,183$564,964.8875.9993%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2006-07-21.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragal sp. z o.o.
Modrzewscy sp. j.
Ms-Pharm sp. z o.o. + limited partnership
Farmjug Ag sp. z o.o.
Magmax S.A.
Adpharma sp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusik sp. j.
Novopharm - Miller sp. j.
Pikada sp. z o.o.
Vita sp. z o.o.

Change history

DateEvent
2018-01-10Share capital increase
2015-06-18PKD change
2010-02-05Switch to PKD 2007
2008-08-28Address change
2008-04-17Share capital increase

FAQ

Last updated: 2026-06-14